Cytokines and cancer development

Journal of Surgical Oncology

Volumn 95, Issue 1, 2007, Pages 10-11

  Miki, Chikao ^a   Inoue, Yasuhiro ^a   Araki, Toshimitsu ^a   Uchida, Keiichi ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6;

CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; EDITORIAL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL GROWTH PROCESSES; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-1BETA; LYMPHOCYTES; NEOPLASMS; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION;

EID: 33846318886     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20541     Document Type: Editorial

References (5)

1. Miki C, Tonouchi H, Wakuda R, et al.: Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma. Cancer 2002;94:1584-1592.
2. Konishi N, Miki C, Yoshida T, et al.: Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology 2005;68:138-145.
3. Shen WH, Zhou JH, Broussard SR, et al.: Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res 2002;62:4746-4756.
4. Goldberg RM: Advances in the treatment of metastatic colorectal cancer. Oncologist 2005;10:40-48.
5. Altinoz MA, Korkmaz R: NF-kB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 2004;51:239-247.